Danimer Scientific, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 10.95 million compared to USD 15.32 million a year ago. Net loss was USD 39.43 million compared to USD 28.05 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 0.28 a year ago.
For the full year, revenue was USD 46.68 million compared to USD 53.22 million a year ago. Net loss was USD 155.47 million compared to USD 179.76 million a year ago. Basic loss per share from continuing operations was USD 1.52 compared to USD 1.78 a year ago.